Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Gene discovery could curb malaria spread
Only the female mosquito bites people and animals to feed on blood and spread disease.

'Femaleless' gene can be manipulated to prevent female mosquitoes from developing.

Scientists at The Pirbright Institute have discovered a new gene that determines the sex of malaria mosquitoes.

Only the female mosquito bites people and animals to feed on blood and spread disease.
Researchers say the new gene, named femaleless, can be manipulated to prevent female mosquitoes from developing - and could therefore provide a new means for the genetic control of mosquito populations. 

The study was led by scientists from the Vector Molecular Biology Group and published in Current Biology

In the study, researchers first identified femaleless in the mosquito Anopheles gambiae, a primary malaria carrier in Africa. Their experiments revealed that by decreasing the gene expression in mosquito eggs, females develop a more male-like appearance and cannot mate or feed on blood. 

The scientists also discovered that femaleless is exclusive to mosquito species belonging to the genus Anopheles, which is solely responsible for transmitting human malaria. The gene was detected in all Anopheles species studied, and its genetic sequence proved to be similar in different species. 

Dr Jaroslaw Krzywinski, head of the Vector Molecular Biology Group at Pirbright, explains: “We first investigated femaleless because we suspected it would have a role in sex determination, but it was unexpected that knockdown of the gene’s expression would lead to female lethality. 

“This gene is highly conserved in sequence and function in various Anopheles species and, as such, provides an excellent universal target to eliminate females of major malaria vector species, enabling the control of their populations. We hope that this discovery could help us to tackle one of the most devastating insect-borne diseases in the world.”

According to the World Health Organisation, there were an estimated 229 million clinical cases of malaria in 2019 and more than 400,000 deaths globally. Children under five are the most vulnerable group affected by the disease, accounting for 67 per cent of all malaria deaths in 2019. 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.